Loranthus.
Loranthus is a mistletoe-like leaf that lives on other trees and carries quercetin-type flavonoids. What is known about it comes from laboratory work, not studies in people.
- Category
- Herb
What Loranthus is, and what it does.
- Does it work
- It suits people following a traditional preparation that names this leaf by species. If you want human outcome data behind an ingredient, this one doesn't have it yet.
- How much to take
- No dose figure is on record for loranthus, and we won't invent one. Traditional use is an infusion or decoction of the dried leaf.
- Time to feel it
- Nobody has measured a time course for loranthus in people, so there is no honest duration we can give you here.
- The first dose
- Day one is a mild, slightly astringent infusion. No day-one effect has been measured, so the honest answer is that nobody has looked.
- With regular use
- Weeks of daily use have not been studied in people. What this leaf contributes over time is unmeasured rather than absent.
- How well tolerated
- Identity and host tree both matter here, since the plant takes up what its host carries and some mistletoe-type plants hold lectins. Buy species-identified material.
- How it feels
- A plain, slightly astringent leaf infusion. Most people report no distinct sensation from drinking it.
- The overlooked benefit
- Because it feeds off its host, the tree it grew on is part of the raw material. Two batches from two host species are not the same leaf, which is unusual in botanicals.
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
- Quercetin and flavonoid glycoside content of the leafNarrative review
- Antioxidant activity of leaf extractsIn vitro study
- Host-dependent variation in leaf chemistryNarrative review
- Support for blood pressure already in the normal rangeAnimal study
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
The flavonoid fraction of Loranthus leaf is dominated by quercetin glycosides. Adding isolated quercetin loads the same conjugation and efflux routes rather than opening a new one. Because both compete for the same glucuronidation capacity, the plasma result is not a simple sum.
When a quercetin-type flavonoid donates an electron it becomes a phenoxyl radical. Ascorbate reduces it back, which keeps the flavonoid in its active form for longer in the aqueous phase. This is established redox chemistry and does not by itself predict any clinical outcome.
Tocopherol intercepts lipid peroxyl radicals inside membranes and is itself regenerated at the membrane surface by water-soluble reductants. Flavonoids from Loranthus sit in that water-soluble pool. The partition between compartments is why the combination is complementary rather than redundant.
Astragalus polysaccharides and Loranthus leaf extract are both positioned around immune signalling. Combining them stacks two poorly characterised immunomodulating inputs. That is a reason for caution in anyone taking immunosuppressive medication, not a reason to assume a larger effect.
Reishi contributes beta-glucans that engage dectin-1 and related pattern recognition receptors. Loranthus extracts have been screened for immunomodulating activity in laboratory systems. Both act on immune signalling in ways that are direction-dependent, so stacking them is not automatically additive and could pull in either direction.
Elderberry anthocyanins and Loranthus flavonoids belong to the same broad polyphenol family and share absorption and conjugation routes. In a blend they compete for that capacity. The pairing is a formulation convention in seasonal products rather than a tested combination.
Polyphenol-rich leaf infusions form insoluble complexes with dietary and supplemental iron before it can be taken up. This is the same effect documented for tea and coffee. Spacing an iron dose a few hours from the infusion avoids it.
Long-chain alkyl gallates and related lipophilic phenolics need a lipid phase to disperse. A medium chain triglyceride carrier keeps them in solution through the stomach and presents them in mixed micelles. This is a physical delivery argument, not a measured bioavailability figure.
Oxidised flavonoids can form reactive quinone intermediates that are handled by glutathione S-transferase conjugation. That consumes glutathione. At ordinary intakes this is a routine metabolic step, and it is a reason the antioxidant framing of high-dose polyphenols is more complicated than it sounds.
Nothing specific on file for Loranthus. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Loranthus actually does.
Loranthus is a partly parasitic plant that draws water and minerals from a host tree it grows on. Because of that, its leaf chemistry changes depending on which tree it grew on, so the host tree matters for what's actually in the raw material.
Because it concentrates what it pulls from its host tree, a plant growing on a toxic or heavily sprayed tree can carry that material into the harvested leaf. This is a contamination route specific to parasitic plants like this one.
The leaf's main flavonoids are quercetin and related glycosides, along with catechins and phenolic acids.
Mistletoe-type plants in this group can build up lectins and viscotoxins. Whether a given preparation contains them depends on the exact species and plant part used, so knowing the precise species matters more here than for most leaf ingredients.
Where Loranthus comes from.
Loranthus is a mistletoe-like plant that grows on the branches of other trees and feeds off them. Because it takes up whatever the host tree is carrying, two batches from two different host trees are not the same material. What is known about it comes from laboratory work, not from studies in people.
Made from a plant. What ends up in the capsule tracks the harvest, so batch testing and a stated marker matter more here than with a made molecule.
A hemiparasitic epiphyte in the Loranthaceae, growing on branches of trees such as guava, kola, citrus and cocoa across West Africa and tropical Asia. Loranthus micranthus is the species most represented in the published work. The host tree is part of the raw material identity, not a footnote.
Leaf is stripped from the woody stems and dried out of direct sun to limit flavonoid degradation.
Water infusion for traditional preparations, alcohol or methanol for research-grade and standardised extracts. The two produce materially different constituent profiles.
Solvent is stripped under vacuum and the residue spray dried, usually onto maltodextrin.
Standardisation is usually to total flavonoids expressed as quercetin equivalents, because no single accepted marker compound has been settled for the genus.
Supplied as a dried extract powder or a fluid extract. Species and host tree should both appear on the certificate of analysis.
The forms it comes in.
The essence, in one line each.
- Leaf extracts of the epiphytic Loranthus micranthus showed immunomodulatory activity, and the activity differed depending on which host tree the plant was collected from.In vitro study. Idoko ND et al., 2024 (BMC Complementary Medicine and Therapies). PMID 38166988 ↗
- 3-O-methyl-alkylgallates inhibited fatty acid desaturation in a mycobacterial system, characterising the compound class rather than the whole plant.In vitro study. Rehberg N et al., 2019 (Antimicrobial Agents and Chemotherapy). PMID 31209015 ↗
These are the studies our verdict leans on, chosen from the 2 we read for Loranthus. The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.